203 related articles for article (PubMed ID: 16803511)
41. CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
Bradly DP; Gattuso P; Pool M; Basu S; Liptay M; Bonomi P; Buckingham L
Diagn Mol Pathol; 2012 Dec; 21(4):207-13. PubMed ID: 23111194
[TBL] [Abstract][Full Text] [Related]
42. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
[TBL] [Abstract][Full Text] [Related]
43. Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma.
Xue WC; Chan KY; Feng HC; Chiu PM; Ngan HY; Tsao SW; Cheung AN
J Mol Diagn; 2004 Nov; 6(4):326-34. PubMed ID: 15507671
[TBL] [Abstract][Full Text] [Related]
44. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
Tanaka T; Bai T; Yukawa K; Umesaki N
Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
[TBL] [Abstract][Full Text] [Related]
45. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
[TBL] [Abstract][Full Text] [Related]
46. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.
Liu Y; Gao W; Siegfried JM; Weissfeld JL; Luketich JD; Keohavong P
BMC Cancer; 2007 May; 7():74. PubMed ID: 17477876
[TBL] [Abstract][Full Text] [Related]
47. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
[TBL] [Abstract][Full Text] [Related]
48. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
Sugita H; Iida S; Inokuchi M; Kato K; Ishiguro M; Ishikawa T; Takagi Y; Enjoji M; Yamada H; Uetake H; Kojima K; Sugihara K
Oncol Rep; 2011 Feb; 25(2):513-8. PubMed ID: 21152877
[TBL] [Abstract][Full Text] [Related]
49. Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells.
Bai T; Tanaka T; Yukawa K; Maeda M; Umesaki N
Oncol Rep; 2004 Mar; 11(3):661-5. PubMed ID: 14767518
[TBL] [Abstract][Full Text] [Related]
50. CpG island methylation in premalignant stages of gastric carcinoma.
Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG
Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456
[TBL] [Abstract][Full Text] [Related]
51. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.
Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I
Anticancer Res; 2010 Jan; 30(1):239-44. PubMed ID: 20150642
[TBL] [Abstract][Full Text] [Related]
52. Expression and methylation status of the Syk gene in cervical carcinoma.
Zhao S; Sun G; Tony PW; Ma D; Zhao C
Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients.
Ye M; Li D; Zhou F; Guo Q; Xia B
Eur J Cancer Prev; 2012 May; 21(3):241-6. PubMed ID: 21979297
[TBL] [Abstract][Full Text] [Related]
54. Promoter Methylation and Relative mRNA Expression of the p16 Gene in Cervical Cancer in North Indians.
Gupta A; Ahmad MK; Mahndi AA; Singh R; Pradeep Y
Asian Pac J Cancer Prev; 2016; 17(8):4149-54. PubMed ID: 27644676
[TBL] [Abstract][Full Text] [Related]
55. Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.
Su Y; Xu H; Xu Y; Yu J; Xian Y; Luo Q
Hematology; 2012 Jan; 17(1):41-6. PubMed ID: 22549447
[TBL] [Abstract][Full Text] [Related]
56. Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells.
Tanaka T; Bai T; Toujima S; Utsunomiya T; Matsuoka T; Kobayashi A; Yamamoto M; Sasaki N; Tanizaki Y; Utsunomiya H; Tanaka J; Yukawa K
Oncol Rep; 2012 Apr; 27(4):1292-8. PubMed ID: 22246465
[TBL] [Abstract][Full Text] [Related]
57. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
[TBL] [Abstract][Full Text] [Related]
58. Promoter hypermethylation patterns of P16, DAPK and MGMT in oral squamous cell carcinoma: a systematic review and meta-analysis.
Don KR; Ramani P; Ramshankar V; Sherlin HJ; Premkumar P; Natesan A
Indian J Dent Res; 2014; 25(6):797-805. PubMed ID: 25728117
[TBL] [Abstract][Full Text] [Related]
59. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.
Lee TL; Leung WK; Chan MW; Ng EK; Tong JH; Lo KW; Chung SC; Sung JJ; To KF
Clin Cancer Res; 2002 Jun; 8(6):1761-6. PubMed ID: 12060614
[TBL] [Abstract][Full Text] [Related]
60. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.
Chan MW; Chan LW; Tang NL; Tong JH; Lo KW; Lee TL; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
Clin Cancer Res; 2002 Feb; 8(2):464-70. PubMed ID: 11839665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]